CENTOGENE's Chief Medical and Genomic Officer Peter Bauer recently sat down with Clinical Trials Arena to discuss the importance of genetic testing in Parkinson’s disease patient care. To hear more from Peter and how the latest data from our ROPAD Study demonstrates that identification of gene variants plays a key role in accelerating potential treatment options, visit: https://lnkd.in/e6AXgy5k #Parkinsons #Research #Science #Publication #Collaboration #Innovation #Genetics #ROPAD #CENTOGENE
More context on the importance of genetic testing in Parkinson’s Disease.
CCO
4moROPAD is a hugely innovative study. We need more of this!